# Archrock, Inc.: financial statements, quarterly

AROC · NYSE · CIK 1389050 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aroc.md) · [Financials](/companies/aroc/financials.md) · [Filings](/companies/aroc/filings.md) · [Insiders](/companies/aroc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/aroc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [253](/filings/0001389050-24-000041.md) | [260 d](/filings/0001389050-26-000009.md) | [268](/filings/0001389050-25-000019.md) | [271](/filings/0001389050-25-000030.md) | [292](/filings/0001389050-25-000038.md) | [326 d](/filings/0001389050-26-000009.md) | [347](/filings/0001389050-26-000019.md) | [383](/filings/0001389050-26-000028.md) | [382](/filings/0001389050-25-000038.md) | [377 d](/filings/0001389050-26-000009.md) | [374](/filings/0001389050-26-000019.md) | [371](/filings/0001389050-26-000028.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | not reported | [113](/filings/0001389050-25-000019.md) | [112](/filings/0001389050-25-000030.md) | [130](/filings/0001389050-25-000038.md) | [151 d](/filings/0001389050-26-000009.md) | [164](/filings/0001389050-26-000019.md) | [174](/filings/0001389050-26-000028.md) | [185](/filings/0001389050-25-000038.md) | [200 d](/filings/0001389050-26-000009.md) | [178](/filings/0001389050-26-000019.md) | [173](/filings/0001389050-26-000028.md) |
| Selling, general and administrative | $m | [28.6](/filings/0001389050-24-000041.md) | [33.0 d](/filings/0001389050-26-000009.md) | [31.7](/filings/0001389050-25-000019.md) | [31.2](/filings/0001389050-25-000030.md) | [34.1](/filings/0001389050-25-000038.md) | [42.2 d](/filings/0001389050-26-000009.md) | [37.2](/filings/0001389050-26-000019.md) | [36.2](/filings/0001389050-26-000028.md) | [37.7](/filings/0001389050-25-000038.md) | [36.7 d](/filings/0001389050-26-000009.md) | [45.2](/filings/0001389050-26-000019.md) | [39.6](/filings/0001389050-26-000028.md) |
| Interest expense | $m | [28.3](/filings/0001389050-23-000052.md) | [27.9 d](/filings/0001389050-24-000007.md) | [27.3](/filings/0001389050-24-000025.md) | [27.9](/filings/0001389050-25-000030.md) | [30.2](/filings/0001389050-25-000038.md) | [38.2 d](/filings/0001389050-26-000009.md) | [37.7](/filings/0001389050-26-000019.md) | [41.7](/filings/0001389050-26-000028.md) | [43.7](/filings/0001389050-25-000038.md) | [42.2 d](/filings/0001389050-26-000009.md) | [39.5](/filings/0001389050-26-000019.md) | [37.0](/filings/0001389050-26-000028.md) |
| Income tax | $m | [11.5](/filings/0001389050-24-000041.md) | [9.7 d](/filings/0001389050-26-000009.md) | [13.1](/filings/0001389050-25-000019.md) | [13.1](/filings/0001389050-25-000030.md) | [15.4](/filings/0001389050-25-000038.md) | [18.6 d](/filings/0001389050-26-000009.md) | [21.1](/filings/0001389050-26-000019.md) | [22.4](/filings/0001389050-26-000028.md) | [25.4](/filings/0001389050-25-000038.md) | [31.9 d](/filings/0001389050-26-000009.md) | [23.4](/filings/0001389050-26-000019.md) | [25.8](/filings/0001389050-26-000028.md) |
| Net income | $m | [30.9](/filings/0001389050-24-000041.md) | [33.0 d](/filings/0001389050-26-000009.md) | [40.5](/filings/0001389050-25-000019.md) | [34.4](/filings/0001389050-25-000030.md) | [37.5](/filings/0001389050-25-000038.md) | [59.8 d](/filings/0001389050-26-000009.md) | [70.9](/filings/0001389050-26-000019.md) | [63.4](/filings/0001389050-26-000028.md) | [71.2](/filings/0001389050-25-000038.md) | [117 d](/filings/0001389050-26-000009.md) | [73.8](/filings/0001389050-26-000019.md) | [66.7](/filings/0001389050-26-000028.md) |
| Diluted EPS | $ per share | [0.20](/filings/0001389050-24-000041.md) | not reported | [0.26](/filings/0001389050-25-000019.md) | [0.22](/filings/0001389050-25-000030.md) | [0.22](/filings/0001389050-25-000038.md) | not reported | [0.40](/filings/0001389050-26-000019.md) | [0.36](/filings/0001389050-26-000028.md) | [0.40](/filings/0001389050-25-000038.md) | not reported | [0.41](/filings/0001389050-26-000019.md) | [0.38](/filings/0001389050-26-000028.md) |
| Basic EPS | $ per share | [0.20](/filings/0001389050-24-000041.md) | not reported | [0.26](/filings/0001389050-25-000019.md) | [0.22](/filings/0001389050-25-000030.md) | [0.22](/filings/0001389050-25-000038.md) | not reported | [0.40](/filings/0001389050-26-000019.md) | [0.36](/filings/0001389050-26-000028.md) | [0.40](/filings/0001389050-25-000038.md) | not reported | [0.41](/filings/0001389050-26-000019.md) | [0.38](/filings/0001389050-26-000028.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.5](/filings/0001389050-23-000052.md) | [1.3](/filings/0001389050-25-000009.md) | [1.2](/filings/0001389050-24-000025.md) | [0.9](/filings/0001389050-24-000035.md) | [3.7](/filings/0001389050-24-000041.md) | [4.4](/filings/0001389050-26-000009.md) | [4.8](/filings/0001389050-25-000019.md) | [5.9](/filings/0001389050-25-000030.md) | [4.1](/filings/0001389050-25-000038.md) | [1.6](/filings/0001389050-26-000028.md) | [4.5](/filings/0001389050-26-000019.md) | [2.0](/filings/0001389050-26-000028.md) |
| Current assets | $m | [225](/filings/0001389050-23-000052.md) | [213](/filings/0001389050-25-000009.md) | [194](/filings/0001389050-24-000025.md) | [204](/filings/0001389050-24-000035.md) | [245](/filings/0001389050-24-000041.md) | [233](/filings/0001389050-26-000009.md) | [272](/filings/0001389050-25-000019.md) | [376](/filings/0001389050-25-000030.md) | [320](/filings/0001389050-25-000038.md) | [304](/filings/0001389050-26-000028.md) | [309](/filings/0001389050-26-000019.md) | [343](/filings/0001389050-26-000028.md) |
| Total assets | $m | [2,672](/filings/0001389050-23-000052.md) | [2,656](/filings/0001389050-25-000009.md) | [2,663](/filings/0001389050-24-000025.md) | [2,711](/filings/0001389050-24-000035.md) | [3,816](/filings/0001389050-24-000041.md) | [3,824](/filings/0001389050-26-000009.md) | [3,965](/filings/0001389050-25-000019.md) | [4,431](/filings/0001389050-25-000030.md) | [4,407](/filings/0001389050-25-000038.md) | [4,349](/filings/0001389050-26-000028.md) | [4,389](/filings/0001389050-26-000019.md) | [4,443](/filings/0001389050-26-000028.md) |
| Current liabilities | $m | [159](/filings/0001389050-23-000052.md) | [152](/filings/0001389050-25-000009.md) | [153](/filings/0001389050-24-000025.md) | [133](/filings/0001389050-24-000035.md) | [195](/filings/0001389050-24-000041.md) | [189](/filings/0001389050-26-000009.md) | [185](/filings/0001389050-25-000019.md) | [208](/filings/0001389050-25-000030.md) | [205](/filings/0001389050-25-000038.md) | [197](/filings/0001389050-26-000028.md) | [219](/filings/0001389050-26-000019.md) | [246](/filings/0001389050-26-000028.md) |
| Total liabilities | $m | [1,811](/filings/0001389050-23-000052.md) | [1,785](/filings/0001389050-25-000009.md) | [1,781](/filings/0001389050-24-000025.md) | [1,816](/filings/0001389050-24-000035.md) | [2,526](/filings/0001389050-24-000041.md) | [2,501](/filings/0001389050-26-000009.md) | [2,615](/filings/0001389050-25-000019.md) | [3,023](/filings/0001389050-25-000030.md) | [2,985](/filings/0001389050-25-000038.md) | [2,858](/filings/0001389050-26-000028.md) | [2,871](/filings/0001389050-26-000019.md) | [2,891](/filings/0001389050-26-000028.md) |
| Long-term debt | $m | [1,605](/filings/0001389050-23-000052.md) | [1,585](/filings/0001389050-25-000009.md) | [1,567](/filings/0001389050-24-000025.md) | [1,609](/filings/0001389050-24-000035.md) | [2,236](/filings/0001389050-24-000041.md) | [2,198](/filings/0001389050-26-000009.md) | [2,298](/filings/0001389050-25-000019.md) | [2,613](/filings/0001389050-25-000030.md) | [2,560](/filings/0001389050-25-000038.md) | [2,411](/filings/0001389050-26-000028.md) | [2,379](/filings/0001389050-26-000019.md) | [2,348](/filings/0001389050-26-000028.md) |
| Shareholders' equity | $m | [861](/filings/0001389050-24-000041.md) | [871](/filings/0001389050-26-000009.md) | [882](/filings/0001389050-25-000030.md) | [894](/filings/0001389050-25-000038.md) | [1,291](/filings/0001389050-25-000038.md) | [1,324](/filings/0001389050-26-000028.md) | [1,350](/filings/0001389050-26-000028.md) | [1,408](/filings/0001389050-26-000028.md) | [1,422](/filings/0001389050-25-000038.md) | [1,491](/filings/0001389050-26-000028.md) | [1,518](/filings/0001389050-26-000028.md) | [1,552](/filings/0001389050-26-000028.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [120 d](/filings/0001389050-24-000041.md) | [71.7 d](/filings/0001389050-26-000009.md) | [138](/filings/0001389050-25-000019.md) | [70.7 d](/filings/0001389050-25-000030.md) | [96.9 d](/filings/0001389050-25-000038.md) | [124 d](/filings/0001389050-26-000009.md) | [116](/filings/0001389050-26-000019.md) | [127 d](/filings/0001389050-26-000028.md) | [165 d](/filings/0001389050-25-000038.md) | [214 d](/filings/0001389050-26-000009.md) | [186](/filings/0001389050-26-000019.md) | [161 d](/filings/0001389050-26-000028.md) |
| Capital expenditure | $m | [74.5 d](/filings/0001389050-24-000041.md) | [36.7 d](/filings/0001389050-26-000009.md) | [99.8](/filings/0001389050-25-000019.md) | [91.3 d](/filings/0001389050-25-000030.md) | [70.0 d](/filings/0001389050-25-000038.md) | [98.0 d](/filings/0001389050-26-000009.md) | [168](/filings/0001389050-26-000019.md) | [111 d](/filings/0001389050-26-000028.md) | [135 d](/filings/0001389050-25-000038.md) | [87.8 d](/filings/0001389050-26-000009.md) | [113](/filings/0001389050-26-000019.md) | [98.0 d](/filings/0001389050-26-000028.md) |
| Dividends paid | $m | [24.3](/filings/0001389050-26-000009.md) | [24.2](/filings/0001389050-26-000009.md) | [26.0](/filings/0001389050-26-000009.md) | [25.8](/filings/0001389050-26-000009.md) | [27.9](/filings/0001389050-26-000009.md) | [30.7](/filings/0001389050-26-000009.md) | [34.2](/filings/0001389050-26-000028.md) | [33.6](/filings/0001389050-26-000028.md) | [36.9](/filings/0001389050-26-000028.md) | [36.9](/filings/0001389050-26-000028.md) | [39.9](/filings/0001389050-26-000028.md) | [38.6](/filings/0001389050-26-000028.md) |
| Share repurchases | $m | [4.4 d](/filings/0001389050-24-000041.md) | [2.4 d](/filings/0001389050-26-000009.md) | [1.2](/filings/0001389050-25-000019.md) | [0.0 d](/filings/0001389050-25-000030.md) | [12.1 d](/filings/0001389050-25-000038.md) | [0.0 d](/filings/0001389050-26-000009.md) | [0.2](/filings/0001389050-26-000019.md) | [28.8 d](/filings/0001389050-26-000028.md) | [25.4 d](/filings/0001389050-25-000038.md) | [15.8 d](/filings/0001389050-26-000009.md) | [4.4](/filings/0001389050-26-000019.md) | [0.0 d](/filings/0001389050-26-000028.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [154](/filings/0001389050-23-000052.md) | [154](/filings/0001389050-24-000025.md) | [154](/filings/0001389050-24-000035.md) | [154](/filings/0001389050-24-000041.md) | [155](/filings/0001389050-25-000019.md) | [155](/filings/0001389050-25-000030.md) | [166](/filings/0001389050-25-000038.md) | [174](/filings/0001389050-26-000019.md) | [175](/filings/0001389050-26-000028.md) | [175](/filings/0001389050-25-000038.md) | [174](/filings/0001389050-26-000019.md) | [175](/filings/0001389050-26-000028.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 175,338,185 at 2026-07-29, from the cover of the [10-Q filed 2026-08-05](/filings/0001389050-26-000028.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.